Education
About Us
Working with TipRanks
Follow Us
Elanco Animal Health (ELAN)
NYSE:ELAN
Earnings Data
Report Date
May 13, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.31Last Year’s EPS
0.34Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 25, 2025
|% Change Since: -3.78%
|Next Earnings Date:May 13, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and successful debt reduction, driven by innovation and strategic execution in both Pet Health and Farm Animal segments. However, the call also acknowledged challenges due to foreign exchange headwinds and slower than expected adoption of certain products. Overall, the sentiment was cautiously optimistic, with a focus on continued growth and innovation.Company Guidance
During Elanco Animal Health's fourth-quarter 2024 earnings call, the company provided guidance for 2025, projecting an acceleration in organic constant currency revenue growth of 4% to 6% and an adjusted EBITDA growth of 1% to 5%, excluding foreign exchange (FX) and the divestiture of their aqua business. The guidance reflects confidence in their six blockbuster products and strategic initiatives, including a focus on growth, innovation, and cash flow. Elanco anticipates continued contributions from their innovation portfolio, with expected innovation revenues of $640 million to $720 million, up from $461 million in 2024. Despite FX headwinds, the company is committed to expanding margins and investing strategically in key product launches. Net leverage is expected in the low to mid-4s by year-end 2025, with potential for improvement depending on currency movements.Sixth Straight Quarter of Revenue Growth
Elanco reported its sixth consecutive quarter of revenue growth, with a 4% increase on an organic constant currency basis for Q4 2024.
Successful Innovation Portfolio
Elanco exceeded its 2024 innovation revenue target, achieving $461 million versus the target of $420 million to $450 million, and increased their expectation for 2025 to $640 million to $720 million.
Debt Reduction
Elanco paid down approximately 25% of its debt in 2024, reducing net leverage to 4.3 times from 5.6 times at the start of the year.
Positive Pet Health Segment Performance
International pet health grew 11% in constant currency, driven by AdTab and Seresto, while U.S. pet health grew 2% with positive contributions from Zenrelia.
Experior Reaches Blockbuster Status
Experior became the first farm animal blockbuster in over a decade, showing strong growth supported by FDA Combo clearance for use in heifers.
---
ELAN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ELAN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 25, 2025 | $11.11 | $10.70 | -3.69% |
| Nov 07, 2024 | $12.86 | $14.50 | +12.75% |
| Aug 08, 2024 | $12.38 | $12.99 | +4.93% |
| May 08, 2024 | $13.52 | $16.89 | +24.93% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Elanco Animal Health (ELAN) report earnings?
Elanco Animal Health (ELAN) is schdueled to report earning on May 13, 2025, TBA Not Confirmed.
What is Elanco Animal Health (ELAN) earnings time?
Elanco Animal Health (ELAN) earnings time is at May 13, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ELAN EPS forecast?
ELAN EPS forecast for the fiscal quarter 2025 (Q1) is 0.31.
---
